Cerus Corp CMO Resigns, Transition Plan in Place
Ticker: CERS · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1020214
| Field | Detail |
|---|---|
| Company | Cerus Corp (CERS) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, personnel-change, medical-devices
TL;DR
CMO Swisher out at Cerus, staying till year-end or replacement. Consulting gig follows.
AI Summary
On June 16, 2025, Cerus Corporation announced the resignation of Dr. William L. Swisher as Chief Medical Officer. The company has not yet appointed a successor, and Dr. Swisher will continue to serve in his role until a replacement is found or until December 31, 2025, whichever comes first. He will also provide consulting services for a transition period.
Why It Matters
The departure of a Chief Medical Officer can signal shifts in a company's R&D strategy or leadership focus, potentially impacting future product development and clinical trial progress.
Risk Assessment
Risk Level: medium — The departure of a key executive like the CMO can create uncertainty regarding leadership and strategic direction, potentially impacting investor confidence.
Key Numbers
- 1231 — Fiscal Year End (Indicates the company's financial reporting cycle.)
Key Players & Entities
- Cerus Corporation (company) — The company filing the report.
- Dr. William L. Swisher (person) — Chief Medical Officer who resigned.
- June 16, 2025 (date) — Date of the earliest event reported.
- December 31, 2025 (date) — Latest possible date for Dr. Swisher's continued service.
FAQ
What is the effective date of Dr. Swisher's resignation?
Dr. Swisher's resignation is effective as of June 16, 2025, though he will continue to serve until a successor is appointed or December 31, 2025.
Will Dr. Swisher receive any compensation after his resignation?
Yes, Dr. Swisher will provide consulting services for a transition period following his departure.
Has Cerus Corporation appointed a successor for the Chief Medical Officer role?
No, the filing states that the company has not yet appointed a successor.
What is the maximum duration Dr. Swisher will remain with the company?
Dr. Swisher will remain with the company until a successor is found or until December 31, 2025, whichever occurs first.
What is the primary business of Cerus Corporation?
Cerus Corporation is in the business of Surgical & Medical Instruments & Apparatus, with SIC code 3841.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 by Dr. William L. Swisher regarding CERUS CORP (CERS).